hepatic encephalopathy
hepatic encephalopathy
Explore linked clinical trials. Standard reference: MONDO:000171147 results · Page 1 of 2
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| RTX001 Autologous Engineered Macrophages for Liver Cirrhosis | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Jaundice, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Skin Manifestations, brain disorder, central nervous system disorder, chronic liver failure, cirrhosis of liver, hepatic encephalopathy, hyperbilirubinemia, liver disorder, liver failure, metabolic disease, nervous system disorder | Active, not recruiting | Phase 1 / Phase 2 | 2026-10-05 | NCT06823713 | |
| Electronic PHES vs Paper-based PHES for Hepatic Encephalopathy | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Not yet recruiting | Not applicable | 2026-10-01 | NCT07852416 | |
| A Prospective Cohort Study on the Epidemiological Investigation, Diagnosis, and Treatment of Hepatic Encephalopathy | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Not yet recruiting | Not stated | 2026-10-01 | NCT07612670 | |
| Late Evening and Early Morning Protein Supplement to Reduce Readmissions for Hepatic Encephalopathy | Brain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Recruiting | Not applicable | 2026-09-25 | NCT04096014 | |
| Daridorexant for Sleep Disturbance in Adults With Liver Cirrhosis | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Parasomnias, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, psychiatric disorder, sleep disorder, sleep-wake disorder | Not yet recruiting | Phase 4 | 2026-09-21 | NCT07830303 | |
| RENEW: Study of Porcine Liver Support in Participants With Acute-on-Chronic Liver Failure | Acute-On-Chronic Liver Failure, Brain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, acute liver failure, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-21 | NCT07429838 | |
| Coil-Assisted Small-Diameter Covered-Stent Shunt Reduction for Refractory Hepatic Encephalopathy After TIPS | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension | Recruiting | Not applicable | 2026-09-02 | NCT07799948 | |
| Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Inflammation, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Active, not recruiting | Phase 2 | 2026-08-25 | NCT06052176 | |
| TReatment for ImmUne Mediated PathopHysiology | Brain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, acute liver failure, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Active, not recruiting | Phase 2 | 2026-08-12 | NCT04862221 | |
| Affect of Melatonin on Sleep and Cognition in Cirrhosis | Brain Diseases, Metabolic, Digestive System Diseases, Dyssomnias, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Parasomnias, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sleep Disorders, Intrinsic, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, insomnia, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension, psychiatric disorder, sleep-wake disorder | Recruiting | Not applicable | 2026-07-29 | NCT07046429 | |
| Appropriate Management of Hepatic EncePhalopaThy AmonG cirrhOtic patieNts Admitted to Internal Medicine | Brain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Active, not recruiting | Not stated | 2026-07-27 | NCT07727070 | |
| Fecal Microbiota Transplantation for the Treatment of Refractory Hepatic Encephalopathy After TIPS Surgery | Brain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Recruiting | Early phase 1 | 2026-07-06 | NCT07683936 | |
| Pre-emptive RTO for An Early Detected Gastric Varices in CT/MR Angiogram Trial | Brain Diseases, Metabolic, Digestive System Diseases, Gastric Varix, Hemorrhage, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, cardiovascular disorder, central nervous system disorder, digestive system disorder, esophageal disorder, esophageal varices, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension, varicose disease, vascular disorder | Not yet recruiting | Not applicable | 2026-07-02 | NCT07168395 | |
| 4D-Flow MRI Assessment of Portal Hypertension and TIPS Outcomes in Cirrhosis | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension | Not yet recruiting | Not applicable | 2026-06-24 | NCT07554183 | |
| Comparison of Underdilated Versus Standard TIPS in Preventing Variceal Rebleeding in Patients With Cirrhosis | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Recruiting | Not applicable | 2026-06-09 | NCT07253389 | |
| Underdilated VCX-TIPS Versus EVL Plus NSBB for Secondary Prophylaxis of Variceal Bleeding in Cirrhosis | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, digestive system disorder, esophageal disorder, esophageal varices, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension | Not yet recruiting | Not applicable | 2026-05-14 | NCT07587671 | |
| Endoscopic Shunts Embolization for Refractory Hepatic Encephalopathy | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Not yet recruiting | Not applicable | 2026-04-28 | NCT07553858 | |
| Microbiota trAnSplant ThERaPy In hEpatiC Encephalopathy (MASTERPIECE) | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Not yet recruiting | Phase 2 | 2026-04-14 | NCT07528690 | |
| Apixaban-PK Trial: Preventing Portal Hypertension Complications in Cirrhosis | Ascites, Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, digestive system disorder, esophageal disorder, esophageal varices, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, portal hypertension, portal vein thrombosis | Recruiting | Phase 4 | 2026-04-09 | NCT07521332 | |
| Evaluation of the Outcome of Fecal Microbiota Transplantation | Brain Diseases, Metabolic, Digestive System Diseases, Hepatic Insufficiency, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Not yet recruiting | Phase 1 / Phase 2 | 2026-03-06 | NCT07454408 | |
| Clinical Efficacy and Survival Prediction Analysis of Transjugular Intrahepatic Portosystemic Shunt in Patients With Liver Cirrhosis | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Active, not recruiting | Not stated | 2026-02-27 | NCT07437638 | |
| A PROspective Faecal MIcrobiota tranSplantation Trial to Improve outcomEs in Patients With Cirrhosis | Brain Diseases, Metabolic, Chemically-Induced Disorders, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Infections, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, alcohol-induced disorders, alcohol-related disorders, alcoholic fatty liver disease, alcoholic liver disease, brain disorder, central nervous system disorder, cirrhosis of liver, fatty liver disease, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, metabolic dysfunction-associated steatotic liver disease, nervous system disorder, substance-related disorder | Recruiting | Phase 3 | 2026-02-24 | NCT06461208 | |
| The Liver Cirrhosis Cognitive Decline Scale (LiCCoS) | Brain Diseases, Metabolic, Cognition Disorders, Cognitive Dysfunction, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, cognitive disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder, psychiatric disorder | Recruiting | Not stated | 2026-02-18 | NCT07418008 | |
| Development of a Cognitive Tool for Rapid and Reliable Screening of Minimal Hepatic Encephalopathy: Pilot Study | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Recruiting | Not stated | 2026-02-18 | NCT06619106 | |
| Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy | Brain Diseases, Metabolic, Digestive System Diseases, Fibrosis, Hepatic Insufficiency, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, brain disorder, central nervous system disorder, cirrhosis of liver, hepatic encephalopathy, liver disorder, liver failure, metabolic disease, nervous system disorder | Recruiting | Not applicable | 2026-01-30 | NCT06425380 |